Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 45.56%887.06M | -7.37%120.63M | 48.72%232.36M | 6.06%609.42M | 39.50%165.01M | 11.98%157.94M | 7.64%130.23M | -19.57%156.25M | -43.37%574.59M | 0.77%118.28M |
| Cost of revenue | 10.21%526.95M | -17.05%97.27M | 11.51%127.61M | 17.55%478.12M | 42.25%133.74M | 9.16%112.67M | 16.95%117.26M | 4.78%114.44M | -53.15%406.72M | -20.27%94.02M |
| Gross profit | 174.25%360.1M | 80.19%23.36M | 150.54%104.75M | -21.78%131.31M | 28.85%31.26M | 19.68%45.27M | -37.43%12.97M | -50.84%41.81M | 14.64%167.87M | 4,543.59%24.26M |
| Operating expense | 59.27%964.24M | 79.80%245.74M | 31.80%195.63M | 4.26%605.4M | 6.93%158.3M | 8.95%161.99M | -23.40%136.68M | 40.64%148.43M | -24.75%580.69M | -23.24%148.04M |
| Operating profit | -27.43%-604.14M | -79.76%-222.38M | 14.76%-90.88M | -14.84%-474.09M | -2.64%-127.04M | -5.29%-116.73M | 21.55%-123.71M | -420.38%-106.62M | 33.98%-412.82M | 36.00%-123.78M |
| Net non-operating interest income (expenses) | 155.79%13.21M | 100.77%57K | 81.20%-2.8M | 34.82%-23.67M | 101.82%303K | 85.04%-1.65M | -13.74%-7.41M | -601.41%-14.91M | -176.81%-36.31M | -739.89%-16.66M |
| Non-operating interest income | 2,867.89%24.22M | 3,488.57%7.54M | --730K | --816K | --303K | --303K | --210K | --0 | --0 | --0 |
| Non-operating interest expense | -44.90%11.01M | 99.55%7.48M | -76.30%3.53M | -44.95%19.99M | --0 | -87.94%1.33M | -42.47%3.75M | 601.41%14.91M | 261.49%36.31M | 739.89%16.66M |
| Total other finance cost | ---- | ---- | ---- | --4.5M | --0 | --623K | ---- | ---- | ---- | ---- |
| Net investment income | 557.42%17.05M | 8.15%4.82M | 1,045.20%3.74M | -75.28%2.59M | 34.27%-3.26M | -52.95%1.79M | -64.46%4.45M | 55.75%-396K | 309.45%10.49M | -25.41%-4.96M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -54.81M | 0 | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -559.41%-1.85B | -384.63%-1.1B | -6.04M | -240,467.52%-281.23M | -13,763.81%-276.58M | 7,478.76%222.29M | -7,564,500.00%-226.93M | 0 | 100.01%117K | 98.05%-2M |
| Less:Other special charges | 36,350.17%955.19M | --687.38M | --6.04M | 81.63%-2.64M | ---- | ---- | ---- | ---- | -126.90%-14.34M | -111.94%-6.52M |
| Less:Write off | 216.79%899.26M | ---- | ---- | 1,895.40%283.87M | 3,178.36%279.22M | -4,650.36%-222.29M | ---- | ---- | -98.16%14.23M | -87.84%8.52M |
| Other non-operating income (expenses) | -0.52%-5.22M | 112.60%458K | 129.32%563K | -115.05%-5.2M | -98.90%289K | 102.59%71K | -138.99%-3.64M | -209.71%-1.92M | 481.76%34.51M | 820.39%26.18M |
| Income before tax | -218.37%-2.49B | -283.76%-1.37B | 22.96%-95.41M | -93.45%-781.59M | -235.21%-406.28M | 189.74%105.78M | -150.94%-357.24M | -448.34%-123.85M | 71.87%-404.02M | 59.46%-121.2M |
| Income tax | -12.45%4.02M | -27.62%841K | 1.60%1.14M | 0.11%4.59M | -61.61%1.16M | 118.97%1.14M | 121.76%1.16M | 115.52%1.13M | 8.76%4.58M | 105.10%3.01M |
| Net income | -217.02%-2.49B | -282.75%-1.37B | 22.74%-96.56M | -92.41%-786.18M | -228.01%-407.44M | 188.38%104.63M | -150.84%-358.4M | -440.80%-124.97M | 71.63%-408.6M | 48.22%-124.22M |
| Net income continuous operations | -217.03%-2.49B | -282.75%-1.37B | 22.74%-96.56M | -92.41%-786.18M | -228.01%-407.44M | 188.38%104.63M | -150.84%-358.4M | -440.82%-124.97M | 71.63%-408.6M | 48.22%-124.22M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -217.02%-2.49B | -282.75%-1.37B | 22.74%-96.56M | -92.41%-786.18M | -228.01%-407.44M | 188.38%104.63M | -150.84%-358.4M | -440.80%-124.97M | 71.63%-408.6M | 48.22%-124.22M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -217.02%-2.49B | -282.75%-1.37B | 22.74%-96.56M | -92.41%-786.18M | -228.01%-407.44M | 188.38%104.63M | -150.84%-358.4M | -440.80%-124.97M | 71.63%-408.6M | 48.22%-124.22M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -130.08%-28.3 | -163.02%-16.36 | 53.41%-1.23 | -25.51%-12.3 | -103.70%-6.05 | 191.90%2.61 | -81.34%-6.22 | -371.43%-2.64 | 78.79%-9.8 | 37.08%-2.97 |
| Diluted earnings per share | -130.08%-28.3 | -163.02%-16.36 | 53.41%-1.23 | -25.51%-12.3 | -103.39%-6.05 | 149.81%1.4147 | -81.34%-6.22 | -371.43%-2.64 | 78.79%-9.8 | 49.52%-2.9746 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |